UNITY Biotechnology Raises $115M
San Francisco-based UNITY Biotechnology announced on Thursday that it has raised $116M in a Series B funding. The funding came from ARCH Venture Partners, Baillie Gifford, Fidelity Management and Research Company, Partner Fund Management, and Venrock, along with Bezos Expeditions, WuXi PharmaTech and Mayo Clinic Ventures. UNITY said it has named Keith Leonard as CEO as part of the funding; founder and previous CEO Nathaniel "Ned" David becomes President of the company. UNITY on treatments for diseases of aging, such as osteoarthritis, glaucoma, and atherosclerosis.
posted on Friday, October 28, 2016 (Link to more information)
Related companies:
UNITY Biotechnology
Related stories:
> UNITY Biotechnology Adds $35M
> UNITY Biotechnology Finds $55M
> Unity Technologies Raises $12M
> Rambus Buys Unity Semiconductor
> Unity Technologies Buys Digital Monarch Media
silicontap.com Home